Advertisement
Research Article Free access | 10.1172/JCI115338
Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Laffón, A. in: JCI | PubMed | Google Scholar
Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by García-Vicuña, R. in: JCI | PubMed | Google Scholar
Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Humbría, A. in: JCI | PubMed | Google Scholar
Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Postigo, A. in: JCI | PubMed | Google Scholar
Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Corbí, A. in: JCI | PubMed | Google Scholar
Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by de Landázuri, M. in: JCI | PubMed | Google Scholar
Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Sánchez-Madrid, F. in: JCI | PubMed | Google Scholar
Published August 1, 1991 - More info
The VLA-4 (CD49d/CD29) integrin is a cell surface receptor involved in the interaction of lymphoid cells with both extracellular matrix (ECM) and endothelial cells. We have investigated the expression and function of VLA-4 fibronectin (FN) receptors on T cells localized in the inflammed synovium of patients with rheumatoid arthritis (RA). A high proportion of T cells in both synovial membrane (SM) and synovial fluid (SF) expressed the activation antigens AIM (CD69) and gp95/85 (Ea2) as well as an increased number of VLA-4 alpha and beta 1 adhesion molecules, as compared with peripheral blood (PB) T cells from the same patients. Furthermore, the majority of these activated SF T cells were able to adhere to a 38-kD FN proteolytic fragment containing the connecting segment-1 (CS-1) specifically through VLA-4 receptors, whereas a significantly lower proportion of PB T cells displayed this capacity. Therefore, our results show that activated T cells selectively localize at sites of tissue injury in RA disease and provide evidence for the in vivo regulation of the expression and function of the VLA-4 integrin. This regulatory mechanism may enable T cells either to facilitate migration or to persist at sites of inflammation.
Images.